The Lysosomal Acid Lipase Deficiency (LAL-D) Treatment Market is gaining momentum as awareness of rare genetic disorders increases and advancements in biotechnology accelerate the development of targeted therapies. LAL-D is a rare, inherited metabolic disease characterized by the accumulation of cholesterol esters and triglycerides in multiple organs, primarily affecting the liver, spleen, and...